Coeptis Therapeutics (COEP) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free COEP Stock Alerts $0.27 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Coeptis Therapeutics Short Interest DataCurrent Short Interest76,600 sharesPrevious Short Interest150,500 sharesChange Vs. Previous Month-49.10%Dollar Volume Sold Short$27,193.00Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares37,120,000 sharesFloat Size27,350,000 sharesShort Percent of Float0.28%Today's Trading Volume124,250 sharesAverage Trading Volume1,061,622 sharesToday's Volume Vs. Average12% Short Selling Coeptis Therapeutics ? Sign up to receive the latest short interest report for Coeptis Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCOEP Short Interest Over TimeCOEP Days to Cover Over TimeCOEP Percentage of Float Shorted Over Time Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. Coeptis Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202476,600 shares $27,193.00 -49.1%0.3%0.1 $0.36 4/30/2024150,500 shares $46,865.70 -13.7%0.6%0.6 $0.31 4/15/2024174,300 shares $64,055.25 +61.8%0.7%0.7 $0.37 3/31/2024107,700 shares $32,029.98 +171.3%0.5%0.4 $0.30 3/15/202439,700 shares $14,264.21 -76.1%0.2%0.2 $0.36 2/29/2024166,100 shares $96,321.39 +153.6%0.8%0.8 $0.58 Get the Latest News and Ratings for COEP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202465,500 shares $27,182.50 +0.9%0.3%0.4 $0.42 1/31/202464,900 shares $36,993.00 +172.7%0.3%0.5 $0.57 1/15/202423,800 shares $14,518.00 -32.0%0.1%0.2 $0.61 12/31/202335,000 shares $27,436.50 -22.1%0.2%0.3 $0.78 12/15/202344,900 shares $39,512.00 -32.8%0.2%0.4 $0.88 11/30/202366,800 shares $78,156.00 -16.8%0.4%0.7 $1.17 11/15/202380,300 shares $99,572.00 -1.1%0.5%0.9 $1.24 10/31/202381,200 shares $97,846.00 +40.7%0.6%1.2 $1.21 10/15/202357,700 shares $70,394.00 +77.0%0.4%1 $1.22 9/30/202332,600 shares $37,816.00 -44.6%0.2%0.5 $1.16 9/15/202358,800 shares $62,916.00 +31.5%0.4%1 $1.07 8/31/202344,700 shares $46,935.00 -14.2%0.3%0.4 $1.05 8/15/202352,100 shares $57,831.00 -40.4%0.4%0.3 $1.11 7/31/202387,400 shares $107,502.00 -19.1%0.8%0.5 $1.23 7/15/2023108,000 shares $141,480.00 -42.7%1.0%0.5 $1.31 6/30/2023188,600 shares $292,330.00 -79.2%1.7%0.8 $1.55 6/15/2023905,900 shares $1.62 million +233.1%8.4%2 $1.79 5/31/2023272,000 shares $515,440.00 -26.5%2.7%0.6 $1.90 5/15/2023369,800 shares $613,868.00 No Change3.6%1 $1.66 COEP Short Interest - Frequently Asked Questions What is Coeptis Therapeutics' current short interest? Short interest is the volume of Coeptis Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 76,600 shares of COEP short. 0.28% of Coeptis Therapeutics' shares are currently sold short. Learn More on Coeptis Therapeutics' current short interest. What is a good short interest percentage for Coeptis Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of Coeptis Therapeutics' floating shares are currently sold short. Is Coeptis Therapeutics' short interest increasing or decreasing? Coeptis Therapeutics saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 76,600 shares, a decline of 49.1% from the previous total of 150,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Coeptis Therapeutics' float size? Coeptis Therapeutics currently has issued a total of 37,119,000 shares. Some of Coeptis Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Coeptis Therapeutics currently has a public float of 27,350,000 shares. How does Coeptis Therapeutics' short interest compare to its competitors? 0.28% of Coeptis Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Coeptis Therapeutics: OKYO Pharma Limited (0.34%), Brainstorm Cell Therapeutics Inc. (2.01%), Achilles Therapeutics plc (0.04%), Quince Therapeutics, Inc. (6.17%), Estrella Immunopharma, Inc. (0.10%), Surrozen, Inc. (1.66%), MiNK Therapeutics, Inc. (5.18%), Pluri Inc. (0.77%), SAB Biotherapeutics, Inc. (0.30%), Evaxion Biotech A/S (0.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Coeptis Therapeutics stock? Short selling COEP is an investing strategy that aims to generate trading profit from Coeptis Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Coeptis Therapeutics? A short squeeze for Coeptis Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COEP, which in turn drives the price of the stock up even further. How often is Coeptis Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COEP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OKYO Pharma Short Interest Brainstorm Cell Therapeutics Short Interest Achilles Therapeutics Short Interest Quince Therapeutics Short Interest Estrella Immunopharma Short Interest Surrozen Short Interest MiNK Therapeutics Short Interest Pluri Short Interest SAB Biotherapeutics Short Interest Evaxion Biotech A/S Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COEP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.